|
|
-
Rainbow Coral Says Its Partner Nano3D Biosciences Signs Distribution Agreement With MIDSCI
5/13/2013
|
-
Amgen, Zhejiang Beta Sign Agreement To Form JV To Commercialize Vectibix In Chinese Market
5/9/2013
|
-
Amgen Says Vectibix Phase 3 Head-to-Head Study Against Erbitux In MCRC Met Primary Endpoint
5/7/2013
|
|
|
-
Transgenomic Enters Into Collaboration With Amgen
5/6/2013
|
-
Barclays Capital Is Increasing Amgen Inc. (AMGN) FY13 Estimate To 7.37 From 7.26
4/24/2013
|
|
|
|
|
-
Amgen Inc. (AMGN) Has Raised Its 2013 EPS Estimate To 7.05 - 7.35 From 6.85 - 7.15
4/23/2013
|